Federal Register / Vol. 86, No. 25 / Tuesday, February 9, 2021 / Notices 8793 

I. General Information 

A. Does this action apply to me? 

You may be potentially affected by 

this action if you are an agricultural 

producer, food manufacturer, or 

pesticide manufacturer. The following 

list of North American Industrial 

Classification System (NAICS) codes is 

not intended to be exhaustive, but rather 

provides a guide to help readers 

determine whether this document 

applies to them. Potentially affected 

entities may include: 

• Crop production (NAICS code 111). 

• Animal production (NAICS code 

112). 

• Food manufacturing (NAICS code 

311). 

B. What should I consider as I prepare 

my comments for EPA? 

1. Submitting CBI. Do not submit this 

information to EPA through 

regulations.gov or email. Clearly mark 

the part or all of the information that 

you claim to be CBI. For CBI 

information in a disk or CD–ROM that 

you mail to EPA, mark the outside of the 

disk or CD–ROM as CBI and then 

identify electronically within the disk or 

CD–ROM the specific information that 

is claimed as CBI. In addition to one 

complete version of the comment that 

includes information claimed as CBI, a 

copy of the comment that does not 

contain the information claimed as CBI 

must be submitted for inclusion in the 

public docket. Information so marked 

will not be disclosed except in 

accordance with procedures set forth in 

40 CFR part 2. 

2. Tips for preparing your comments. 

When preparing and submitting your 

comments, see the commenting tips at 

https://www.epa.gov/dockets/ 

commenting-epa-dockets. 

II. Registration Applications 

EPA has received applications to 

register new uses for pesticide products 

containing currently registered active 

ingredients. Pursuant to the provisions 

of FIFRA section 3(c)(4) (7 U.S.C. 

136a(c)(4)), EPA is hereby providing 

notice of receipt and opportunity to 

comment on these applications. Notice 

of receipt of these applications does not 

imply a decision by the Agency on these 

applications. 

A. Notice of Receipts—New Uses 

1. Registration Numbers: 7969–335 

(Cyflumetofen Technical) and 7969–336 

(Nealta® Miticide); Decision Nos: 

565033 and 565035. Docket Number: 

EPA–HQ–OPP–2020–0603. Company 

name and address: BASF Corporation, 

Agricultural Products, 26 Davis Drive, 

P.O. Box 13528, Research Triangle Park, 

NC 27709–3528. Active ingredient: 

Cyflumetofen. Proposed use: Hops. 

Contact: RD. 

Authority: 7 U.S.C. 136 et seq. 

Dated: January 21, 2021. 

Delores Barber, 

Director, Information Technology and 

Resources Management Division, Office of 

Pesticide Programs. 

[FR Doc. 2021–02651 Filed 2–8–21; 8:45 am] 

BILLING CODE 6560–50–P 

FEDERAL RESERVE SYSTEM 

Change in Bank Control Notices; 

Acquisitions of Shares of a Bank or 

Bank Holding Company 

The notificants listed below have 

applied under the Change in Bank 

Control Act (Act) (12 U.S.C. 1817(j)) and 

§ 225.41 of the Board’s Regulation Y (12 

CFR 225.41) to acquire shares of a bank 

or bank holding company. The factors 

that are considered in acting on the 

applications are set forth in paragraph 7 

of the Act (12 U.S.C. 1817(j)(7)). 

The public portions of the 

applications listed below, as well as 

other related filings required by the 

Board, if any, are available for 

immediate inspection at the Federal 

Reserve Bank(s) indicated below and at 

the offices of the Board of Governors. 

This information may also be obtained 

on an expedited basis, upon request, by 

contacting the appropriate Federal 

Reserve Bank and from the Board’s 

Freedom of Information Office at 

https://www.federalreserve.gov/foia/ 

request.htm. Interested persons may 

express their views in writing on the 

standards enumerated in paragraph 7 of 

the Act. 

Comments regarding each of these 

applications must be received at the 

Reserve Bank indicated or the offices of 

the Board of Governors, Ann E. 

Misback, Secretary of the Board, 20th 

Street and Constitution Avenue NW, 

Washington, DC 20551–0001, not later 

than February 24, 2021. 

B. Federal Reserve Bank of Kansas 

City (Dennis Denney, Assistant Vice 

President) 1 Memorial Drive, Kansas 

City, Missouri 64198–0001: 

1. Joseph Tutera, Mission Hills, 

Kansas; individually and as a member 

of the Tutera Family Group, a group 

acting in concert, to retain voting shares 

of Central Bancshares of Kansas City 

(Bancshares) and thereby indirectly 

retain voting shares of Central Bank of 

Kansas City, both of Kansas City, 

Missouri. Additionally, Marian Olander 

Tutera, Mission Hills, Kansas; John 

‘‘David’’ Cunningham, Prairie Village, 

Kansas; Anthony Michael Mendolia, 

Constance Marie Mendolia 2009 

Irrevocable Trust dated 12–29–09, 

Joseph Tutera, Trustee, John David 

Cunningham, Trust Protector; Mary 

Margaret Cunningham 2009 Irrevocable 

Trust dated 12–29–09, Joseph Tutera, 

Trustee, Marian Olander Tutera, Trust 

Protector; Joseph C. Tutera 2009 

Irrevocable Trust dated 12–29–09, 

Joseph Tutera, Trustee, John David 

Cunningham, Trust Protector, Laura 

Cirese Tutera 2009 Trust dated 10–8–09, 

Hanna Marie Tutera 2009 Trust dated 

10–8–09, Dominic Frank Tutera 2009 

Trust dated 10–8–09, Dominic Frank 

Tutera 2009 Trust dated 10–8–09, 

Joseph Charles Tutera Jr. 2009 Trust 

dated 10–8–09, David Cunningham, 

Trustee, Anthony Mendolia, Trust 

Protector, all of Kansas City, Missouri; 

to join the Tutera Family Group and 

retain voting shares of Bancshares and 

thereby indirectly retain voting shares of 

Central Bank of Kansas City. 

Board of Governors of the Federal Reserve 

System, February 4, 2021. 

Michele Taylor Fennell, 

Deputy Associate Secretary of the Board. 

[FR Doc. 2021–02670 Filed 2–8–21; 8:45 am] 

BILLING CODE 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier CMS–10320] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including the necessity and 


khammond on DSKJM1Z7X2PROD with NOTICES
8794 Federal Register / Vol. 86, No. 25 / Tuesday, February 9, 2021 / Notices 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions, the accuracy of 

the estimated burden, ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and the use 

of automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

DATES: Comments on the collection(s) of 

information must be received by the 

OMB desk officer by March 11, 2021. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ website address at 

website address at https://www.cms.gov/ 

Regulations-and-Guidance/Legislation/ 

PaperworkReductionActof1995/PRAListing.html. 

FOR FURTHER INFORMATION CONTACT: 

William Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. The term ‘‘collection of 

information’’ is defined in 44 U.S.C. 

3502(3) and 5 CFR 1320.3(c) and 

includes agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. Section 

3506(c)(2)(A) of the PRA (44 U.S.C. 

3506(c)(2)(A)) requires federal agencies 

to publish a 30-day notice in the 

Federal Register concerning each 

proposed collection of information, 

including each proposed extension or 

reinstatement of an existing collection 

of information, before submitting the 

collection to OMB for approval. To 

comply with this requirement, CMS is 

publishing this notice that summarizes 

the following proposed collection(s) of 

information for public comment: 

1. Type of Information Collection 

Request: Extension; Title of Information 

Collection: Health Care Reform 

Insurance Web Portal; Use: Upon 

collection of the data collection 

requirements from individual States, 

State health benefits high risk pools, 

and insurance issuers (hereon referred 

to as issuers), this information is 

processed by contractors for display on 

the HealthCare.gov website. The 

information that is provided helps the 

general public make educated decisions 

about their choice in organizations 

providing private health care insurance. 

Information collected quarterly from 

insurance issuers is used to populate the 

Plan Finder application to show 

individuals their options, to provide 

some profile information, and to 

coordinate the data collection with 

Oversight collections to reduce the 

burden on issuers and the Federal 

Government. Collecting information 

consistent with the SBC standards 

allows consumers to access this 

information in a consistent manner. 

Form Number: CMS–10320 (OMB 

control number 0938–1086); Frequency: 

Occasionally; Affected Public: State, 

Local, and Tribal Governments; Number 

of Respondents: 700; Number of 

Responses: 700; Total Annual Hours: 

78,675. (For questions regarding this 

collection contact Kimberlee Heckstall 

at 410–786–1647.) 

Dated: February 3, 2021. 

William N. Parham, III, 

Director, Paperwork Reduction Staff, Office 

of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2021–02580 Filed 2–8–21; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Current List of HHS-Certified 

Laboratories and Instrumented Initial 

Testing Facilities Which Meet Minimum 

Standards To Engage in Urine and Oral 

Fluid Drug Testing for Federal 

Agencies 

AGENCY: Substance Abuse and Mental 

Health Services Administration, HHS. 

ACTION: Notice. 

SUMMARY: The Department of Health and 

Human Services (HHS) notifies federal 

agencies of the laboratories and 

Instrumented Initial Testing Facilities 

(IITFs) currently certified to meet the 

standards of the Mandatory Guidelines 

for Federal Workplace Drug Testing 

Programs using Urine or Oral Fluid 

(Mandatory Guidelines). 

FOR FURTHER INFORMATION CONTACT: 

Anastasia Donovan, Division of 

Workplace Programs, SAMHSA/CSAP, 

5600 Fishers Lane, Room 16N06B, 

Rockville, Maryland 20857; 240–276– 

2600 (voice); Anastasia.Donovan@

samhsa.hhs.gov (email). 

SUPPLEMENTARY INFORMATION: In 

accordance with Section 9.19 of the 

Mandatory Guidelines, a notice listing 

all currently HHS-certified laboratories 

and IITFs is published in the Federal 

Register during the first week of each 

month. If any laboratory or IITF 

certification is suspended or revoked, 

the laboratory or IITF will be omitted 

from subsequent lists until such time as 

it is restored to full certification under 

the Mandatory Guidelines. 

If any laboratory or IITF has 

withdrawn from the HHS National 

Laboratory Certification Program (NLCP) 

during the past month, it will be listed 

at the end and will be omitted from the 

monthly listing thereafter. 

This notice is also available on the 

internet at https://www.samhsa.gov/ 

workplace/resources/drug-testing/ 

certified-lab-list. 

The Department of Health and Human 

Services (HHS) notifies federal agencies 

of the laboratories and Instrumented 

Initial Testing Facilities (IITFs) 

currently certified to meet the standards 

of the Mandatory Guidelines for Federal 

Workplace Drug Testing Programs 

(Mandatory Guidelines) using Urine and 

of the laboratories currently certified to 

meet the standards of the Mandatory 

Guidelines using Oral Fluid. 

The Mandatory Guidelines using 

Urine were first published in the 

Federal Register on April 11, 1988 (53 

FR 11970), and subsequently revised in 

the Federal Register on June 9, 1994 (59 

FR 29908); September 30, 1997 (62 FR 

51118); April 13, 2004 (69 FR 19644); 

November 25, 2008 (73 FR 71858); 

December 10, 2008 (73 FR 75122); April 

30, 2010 (75 FR 22809); and on January 

23, 2017 (82 FR 7920). 

The Mandatory Guidelines using Oral 

Fluid were first published in the 

Federal Register on October 25, 2019 

(84 FR 57554) with an effective date of 

January 1, 2020. 

The Mandatory Guidelines were 

initially developed in accordance with 

Executive Order 12564 and section 503 

of Public Law 100–71 and allowed urine 

drug testing only. The Mandatory 

Guidelines using Urine have since been 

revised, and new Mandatory Guidelines 

allowing for oral fluid drug testing have 

been published. The Mandatory 

Guidelines require strict standards that 

laboratories and IITFs must meet in 

order to conduct drug and specimen 

validity tests on specimens for federal 

agencies. HHS does not allow IITFs to 

conduct oral fluid testing. 

To become certified, an applicant 

laboratory or IITF must undergo three 


khammond on DSKJM1Z7X2PROD with NOTICES